SCHEMBL6603664

SCHEMBL6603664

CCCC[N]c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.44
NOS1 P29475 2/20 0.44
NOS2 P35228 2/20 0.44
LMNA P02545 4/20 0.43
ALDH1A1 P00352 1/20 0.43
ABCB1 P08183 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
NPC1 O15118 1/20 0.41
HSP90AA1 P07900 1/20 0.41
RAB9A P51151 1/20 0.41
ADRA2A P08913 3/20 0.41
ADRA2B P18089 3/20 0.41
ADRA2C P18825 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7713660 0.88 NOS3 (0.46) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL1629938 0.79
SCHEMBL16592822 0.77 LMNA (0.46) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL16592821 0.77 LMNA (0.46) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL1850348 0.76 ADRA2A (0.48) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL1851035 0.76 ADRA2A (0.40) NOS3NOS1NOS2ALDH1A1MAPT
SCHEMBL10634493 0.76 ADRA2A (0.44) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL28342274 0.74 MAOA (0.52) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL3363776 0.73 NOS3 (0.41) NOS3NOS1NOS2LMNAALDH1A1
SCHEMBL2235378 0.72 NOS3 (0.42) NOS3NOS1NOS2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049691-B1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMA CO LTD (JP) 2004-02-18 EP disclosed
US-6413979-B1 ANTAGONISTS TO ENDOTHELINS; VASODILATORS AND BRONCHODILATORS; SYNTHESIS ROUTES; HYPERTENSION, ASTHMA, RAYNAUD'S DISEASE, RENAL AND HEART FAILURE, ANGINA, DIABETES, CEREBRAL INFARC-TION AND VASOSPASM, ARTERIOSCLEROSIS, RESTENOSIS, PROSTATISM BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-07-02 US disclosed
EP-1049691-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-11-08 EP disclosed
WO-1999037639-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-29 WO disclosed